|
Year |
Beginning Price |
Ending Price |
Gain or Loss |
Percent Gain or Loss |
|
1992 |
43.75 |
23.00 |
-20.75 |
-47.43% |
|
1993 |
23.00 |
11.00 |
-12.00 |
-52.17% |
|
1994 |
11.00 |
3.50 |
-7.50 |
-68.18% |
|
1995 |
3.50 |
20.00 |
16.50 |
471.43% |
|
1996 |
20.00 |
17.00 |
-3.00 |
-15.00% |
|
1997 |
17.00 |
42.875 |
25.875 |
152.21% |
|
1998 |
42.875 |
99.4375 |
56.5625 |
133.92% |
|
1999 |
99.4375 |
331.75* |
232.3125 |
233.63% |
|
2000 |
165.875 |
143.0625* |
-22.8125 |
-13.75% |
|
2001 |
47.6875 |
46.35 |
-1.3375 |
-2.80% |
|
2002 |
46.35 |
27.17 |
-19.18 |
-41.38% |
|
2003 |
27.17 |
25.38 |
-1.79 |
-6.59% |
|
2004 |
25.38 |
27.11 |
1.73 |
6.82% |
|
2005 |
27.11 |
35.02 |
7.91 |
29.18% |
|
2006 |
35.02 |
32.37 |
-2.65 |
-7.57% |
|
2007 |
32.37 |
58.00** |
25.63 |
79.18% |
*The 1999 ending price for MedImmune has been adjusted for a 2 for 1 stock split.
*The 2000 ending price for MedImmune has been adjusted for a 3 for 1 stock split.
** In June 2007 MedImmune was acquired by AstraZeneca (AZN) for $58.00 a share.